Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 40 - 55 |
| Updated: | 4/21/2016 |
| Start Date: | July 2014 |
| End Date: | November 2014 |
A study to evaluate the safety and efficacy of AGN-199201 alone, AGN-190584 alone and
concurrent use of AGN-199201 and AGN-190584 in patients with presbyopia (inability to focus
for near vision).
concurrent use of AGN-199201 and AGN-190584 in patients with presbyopia (inability to focus
for near vision).
Inclusion Criteria:
-Presbyopia in each eye that impacts daily activities.
Exclusion Criteria:
- Use of any topical ophthalmic medications, including artificial tears
- Contact lens use in either eye within 14 days or planned use during the study
- History of eye surgery
- Diagnosis of any type of glaucoma or ocular hypertension
We found this trial at
1
site
Click here to add this to my saved trials
